Accelerating the precision medicine opportunity in Scotland
Accelerating the precision medicine opportunity in Scotland
27/08/2019
9:00 amQueen Elizabeth Teaching and Learning Centre
There are several market and technology drivers impacting on precision medicine including an ageing population, increasing healthcare costs and the emergence of new disruptive technologies. Advances in technology are accelerating a shift in healthcare from reaction to prevention and early stage treatments and the global precision medicine market was estimated at almost $43bn in 2016 and is projected to rise to around $134bn by 2025.
Scotland’s ecosystem for precision medicine includes a strong network of universities, research institutions, NHS facilities, enterprise and skills agencies and industry bodies all focussed on developing, commercialising and implementing our world-class research in precision medicine. Scotland has a growing number of businesses involved in precision medicine, including new start-ups and in-movers involved in developing digital platforms for health data, informatics, AI and machine learning.
How do we make Scotland a world leader in precision medicine?
Agenda:
08.45 – Registration with tea, coffee and networking
09.15 – Open from the chair
Sandy Kennedy, Entrepreneurial Scotland
09.20 – Professor Dame Anna Dominiczak, University of Glasgow
09.50 – Benefits of the Scottish Precision Medicine ecosystem – an industry perspective
Harper Van Steenhouse, Bioclavis
10.15 – Successful IP strategies in Precision Medicine
Magnus Johnston, Haseltine Lake Kempner
10.40 – Discussion in Panel and Q&A
11.05 – Coffee Break
11.30 – Identifying the skill sets required to develop the precision medicine cluster in Scotland
Speaker to be announced
11.55 – Enabling access to funding and investors
Scottish Enterprise
12.20 – Dr Carol Clugston, University of Glasgow
12.50 – Discussion in Panel and Q&A
13.20 – Chair to close
13.30 – Networking lunch
Register